Christopher J. Schmidt

Person

Old Lyme, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Monoamine reuptake inhibitors for treatment of CNS disorders
- Patent number 7,084,165
- Issue date Aug 1, 2006
- Pfizer Inc.
- Harry Ralph Howard, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoamine reuptake inhibitors for treatment of CNS disorders
- Patent number 6,677,378
- Issue date Jan 13, 2004
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20040162293
- Publication date Aug 19, 2004
- Pfizer Inc.
- Lorraine A. Lebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20040162294
- Publication date Aug 19, 2004
- Pfizer Inc.
- Lorraine A. Lebel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoamine reuptake inhibitors for treatment of CNS disorders
- Publication number 20040048856
- Publication date Mar 11, 2004
- Pfizer Inc.
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination treatment for depression and anxiety
- Publication number 20040001895
- Publication date Jan 1, 2004
- Pfizer Inc.
- Susan B. Sobolov-Jaynes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination treatment for depression and anxiety
- Publication number 20030235631
- Publication date Dec 25, 2003
- Pfizer Inc.
- Susan B. Sobolov-Jaynes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Disruption of the phosphodiesterase 10 gene
- Publication number 20030121069
- Publication date Jun 26, 2003
- Pfizer Inc.
- Frank S. Menniti
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030032579
- Publication date Feb 13, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030018047
- Publication date Jan 23, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Therapeutic use of selective PDE10 inhibitors
- Publication number 20030008806
- Publication date Jan 9, 2003
- Pfizer Inc.
- Lorraine A. Lebel
- G01 - MEASURING TESTING
Information Patent Application
Monoamine reuptake inhibitors for treatment of CNS disorders
- Publication number 20020143003
- Publication date Oct 3, 2002
- Harry R. Howard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination treatment for depression and anxiety
- Publication number 20020049211
- Publication date Apr 25, 2002
- Susan Beth Sobolov-Jaynes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher J. Schmidt

Person

Patents Grantslast 30 patents

Monoamine reuptake inhibitors for treatment of CNS disorders

Monoamine reuptake inhibitors for treatment of CNS disorders

Patents Applicationslast 30 patents

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Monoamine reuptake inhibitors for treatment of CNS disorders

Combination treatment for depression and anxiety

Combination treatment for depression and anxiety

Disruption of the phosphodiesterase 10 gene

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Therapeutic use of selective PDE10 inhibitors

Monoamine reuptake inhibitors for treatment of CNS disorders

Combination treatment for depression and anxiety